Cecilia Lorena Basiglio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cecilia Lorena Basiglio has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A L Monje
Área Clínica Médica, Facultad de Ciencias Médicas, Rosario, Argentina
1 shared publicationAlejandra I. Martínez
Área Morfología—Facultad de Ciencias Bioquímicas y Farmacéuticas Rosario Argentina
1 shared publicationB Balbi
Area Bioquímica Clínica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Rosario, Argentina
1 shared publicationE Pezzarini
Area Bioquímica Clínica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Rosario, Argentina
1 shared publicationEnrique J. Sánchez Pozzi
Instituto de Fisiología Experimental (IFISE‐CONICET) Rosario Argentina
1 shared publicationEstefanía M. A. Massa
Área Bioquímica Clínica—Facultad de Ciencias Bioquímicas y Farmacéuticas Rosario Argentina
1 shared publication
Latest Publications
- 8 April 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (4) , e70123
Inhibition of Bilirubin Generation Exacerbates Oxidative Stress and Liver Injury in Early‐to‐Intermediate Obstructive Cholestasis
Objective: We have previously shown that hemeoxygenase‐1 (HO1) induction and resulting elevation of bilirubin (BR) protects the liver from oxidative stress (OS)‐induced acute cholestasis in vivo. Aim: To characterise the protective role of BR at the early‐to‐intermediate stages of obstructive cholestasis by investigating the consequences of inhibiting BR generation in vivo. Methods: Zinc protoporphyrin IX (ZnPP), a HO1 inhibitor, was administered 24 h before BDL to male Wistar rats. After confirming establishment of obstructive cholestasis and successful impairment in BR generation, we studied the impact of these interventions on redox status and histopathological features in liver tissue. Results: OS biomarkers were significantly elevated in ZnPP‐pretreated BDL animals versus BDL‐only controls, showing that under cholestatic conditions, oxidative damage is increased when BR production is impaired. Levels of antioxidant defences were lower in animals lacking BR generation, indicating that hepatic oxidative damage is more severe and antioxidant defences are weaker when BR production is inhibited. Histopathological analysis revealed significantly more severe obstructive injury in HO1‐inhibited animals than in those subjected to BDL alone, indicating that BR generation impairment worsens the outcome of obstructive injury. Conclusions: The inhibition of HO1 and consequent decrease in the endogenous levels of BR negatively impacts the outcome of obstructive cholestasis due to the loss of BR's antioxidant and cytoprotective effects. BR accumulation during cholestasis serves as a critical defence against oxidative damage induced by retained bile salts.
- 8 April 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (4) , e70123
Inhibition of Bilirubin Generation Exacerbates Oxidative Stress and Liver Injury in Early‐to‐Intermediate Obstructive Cholestasis
Objective: We have previously shown that hemeoxygenase‐1 (HO1) induction and resulting elevation of bilirubin (BR) protects the liver from oxidative stress (OS)‐induced acute cholestasis in vivo. Aim: To characterise the protective role of BR at the early‐to‐intermediate stages of obstructive cholestasis by investigating the consequences of inhibiting BR generation in vivo. Methods: Zinc protoporphyrin IX (ZnPP), a HO1 inhibitor, was administered 24 h before BDL to male Wistar rats. After confirming establishment of obstructive cholestasis and successful impairment in BR generation, we studied the impact of these interventions on redox status and histopathological features in liver tissue. Results: OS biomarkers were significantly elevated in ZnPP‐pretreated BDL animals versus BDL‐only controls, showing that under cholestatic conditions, oxidative damage is increased when BR production is impaired. Levels of antioxidant defences were lower in animals lacking BR generation, indicating that hepatic oxidative damage is more severe and antioxidant defences are weaker when BR production is inhibited. Histopathological analysis revealed significantly more severe obstructive injury in HO1‐inhibited animals than in those subjected to BDL alone, indicating that BR generation impairment worsens the outcome of obstructive injury. Conclusions: The inhibition of HO1 and consequent decrease in the endogenous levels of BR negatively impacts the outcome of obstructive cholestasis due to the loss of BR's antioxidant and cytoprotective effects. BR accumulation during cholestasis serves as a critical defence against oxidative damage induced by retained bile salts.
- 16 February 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (3) , 311-323
Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy
Lupus nephropathy is a severe and frequent complication of systemic lupus erythematosus. Here, we assessed the biomarkers of oxidative stress, inflammation and disease activity in patients with lupus nephritis. Thirty-four patients with active lupus nephritis, 31 patients with inactive lupus nephritis and 20 lupus patients without renal damage (non-lupus nephritis) were studied. Oxidative stress biomarkers malonyldialdehyde, oxidized-to-total glutathione, catalase, superoxide dismutase and total antioxidant status were assessed, as well as inflammation biomarkers CRP, interleukin 6 and monocyte chemoattractant protein 1. Renal tubular disease biomarkers neutrophil gelatinase-associated lipocalin and β2-microglobulin were assessed, together with the classic disease activity biomarkers urinary protein/creatinine ratio, anti-dsDNA, anti-C1q antibody and complement proteins C3 and C4. Significant differences were found between active lupus nephritis and inactive lupus nephritis patients and between active lupus nephritis and non-lupus nephritis patients for all the assessed biomarkers (P < 0.05), except for catalase, superoxide dismutase and interleukin 6. There is an imbalance in the redox status in active lupus nephritis patients that would be involved in lipid peroxidation of the glomerular basal membrane that would alter its integrity and could also affect renal tubular function in these patients.
- 16 February 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (3) , 311-323
Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy
Lupus nephropathy is a severe and frequent complication of systemic lupus erythematosus. Here, we assessed the biomarkers of oxidative stress, inflammation and disease activity in patients with lupus nephritis. Thirty-four patients with active lupus nephritis, 31 patients with inactive lupus nephritis and 20 lupus patients without renal damage (non-lupus nephritis) were studied. Oxidative stress biomarkers malonyldialdehyde, oxidized-to-total glutathione, catalase, superoxide dismutase and total antioxidant status were assessed, as well as inflammation biomarkers CRP, interleukin 6 and monocyte chemoattractant protein 1. Renal tubular disease biomarkers neutrophil gelatinase-associated lipocalin and β2-microglobulin were assessed, together with the classic disease activity biomarkers urinary protein/creatinine ratio, anti-dsDNA, anti-C1q antibody and complement proteins C3 and C4. Significant differences were found between active lupus nephritis and inactive lupus nephritis patients and between active lupus nephritis and non-lupus nephritis patients for all the assessed biomarkers (P < 0.05), except for catalase, superoxide dismutase and interleukin 6. There is an imbalance in the redox status in active lupus nephritis patients that would be involved in lipid peroxidation of the glomerular basal membrane that would alter its integrity and could also affect renal tubular function in these patients.